Gateway Safety Solutions delivers senior-level pharmacovigilance consulting at the intersection of clinical expertise, regulatory compliance, and enterprise technology — including AI/ML integration into PV workflows.
Verified LinkedIn recommendations from colleagues, clients, and technology partners
Paul and I worked together on pharmacovigilance digital implementation projects for several years. I was the Client PM and he was the SaaS Provider PM & Business Analyst. I had confidence in his deliverables because of his ability to dig into complexity, figure out the details, understand the big picture, think from the user's perspective, and communicate well with management. Paul would be a great asset to lead or participate with any team.
Paul brings a wide array of skills to the table. He's an exceptional communicator with a real talent for engaging clients and navigating complex requirements. What truly sets Paul apart is his ability to connect with stakeholders across all levels — from C-suite executives to technical analysts — moving seamlessly between strategic and technical discussions on both the pharmacovigilance and IT sides. His versatility and confidence in these moments are rare and deeply valued. Paul is reliable, insightful, and a true partner. If you're lucky enough to work with him, take it.
Paul was instrumental in the migration of safety adverse event data. He led the partner effort in ensuring the data present in the safety database was in acceptable format and with high quality to ensure a smooth transition of critical safety data. His many years of experience with Oracle safety databases gave the team confidence that both migration teams were speaking the same requirements. I have no hesitation in recommending Paul for your Safety Database migrations.
Paul is an absolute pleasure to work with. Among his many talents is his unique skill of being able to translate complex technology details and requirements into simple, practical language — making him a huge asset on any implementation project and a fantastic Project Manager. He is well organized and an incredibly hard worker, quickly forging meaningful and lasting relationships with colleagues and clients alike. A real asset to any company he chooses to work for.
Paul was a tremendous asset in client conversations explaining how AI worked within the pharma industry. His knowledge base was incredible — any question the leadership team had on the pharma subject was easily answered. Paul was instrumental in guiding the AI models in the right directions. I remember when our deep learning algorithms kept flagging a 20-digit number as a strong feature. Paul quickly determined what those numbers meant and showed us how the data was biasing results — allowing us to fix the models. Without Paul, these models would not have survived in production.
I have had the privilege to work with Paul over the years. Paul is an excellent communicator that succeeds in anything he is chartered to do. He is equally comfortable working for pharma and industry as well as a service provider within the PV space. He has a keen awareness of the possibilities and opportunities for AI to revolutionize and automate the day-to-day Drug Safety workplace. His character, personality, and work ethic are above reproach — he takes pride and great care to be the best he can be. I look forward to working with Paul again and highly endorse him based on my experiences across multiple successful projects where he was instrumental in ensuring the desired outcomes were met.
Follow Dr. Reed's professional updates, pharmacovigilance insights, and AI/ML in drug safety content — or reach out directly to discuss an engagement.
Connect on LinkedInWhether you need Argus configuration, GxP validation, or AI/ML implementation — let's talk.
End-to-end pharmacovigilance consulting — from system implementation to AI-powered workflow transformation and regulatory compliance.
Expert configuration, validation, and optimization of enterprise drug safety platforms across all major vendors.
Comprehensive 21 CFR Part 11 compliant validation programs for safety-critical systems.
Next-generation automation for ICSR intake, signal detection, and PV workflow optimization.
Operational support for safety departments navigating resource constraints or scaling challenges.
Strategic guidance on global safety reporting requirements and regulatory compliance frameworks.
Custom training programs for PV teams, safety system users, and cross-functional stakeholders.
End-to-end project leadership for drug safety technology initiatives — from planning through go-live and beyond.
Access to a vetted international network of pharmacovigilance and life sciences technology specialists.
A discovery call is the fastest way to scope your project and get a tailored proposal.
A career built at the intersection of clinical pharmacology, enterprise safety technology, and regulatory compliance.
Deep expertise across all major enterprise pharmacovigilance platforms — from fresh installs and SaaS upgrades to complex multi-system integrations, data migrations, and M&A transitions.
Configuration, validation, and optimization of industry-leading safety databases, including ICSR workflow design, regulatory submission pipelines, and reporting architecture.
Comprehensive computer system validation including IQ/OQ/PQ protocols, audit trails, electronic records/signatures, Annex 11 compliance, and FDA inspection preparedness.
Delivered client implementations of an AI-powered adverse event intake platform through Gateway Safety Solutions. Direct experience with NLP, case triage automation, user adoption programs, and safety system API integration.
EudraVigilance, ICH E2B(R2) & E2B(R3), EU GVP Modules, MedDRA coding, and global ICSR reporting requirements across US and EU regulatory jurisdictions.
End-to-end program leadership for PV technology initiatives — budgets, stakeholders, RFPs, vendor negotiations, go-live support, and post-implementation optimization across global engagements.
Let's discuss your PV program and how Gateway Safety Solutions can help.
Gateway Safety Solutions was founded on a simple premise: the most effective pharmacovigilance consulting comes from someone who has operated at both ends of the spectrum — as a trained clinical pharmacist who understands drug safety from the ground up, and as an enterprise IT professional who has built, validated, and optimized the systems that power global safety programs.
Dr. Paul A. Reed brings over two decades of experience spanning traditional Big Pharma, global CRO environments, and cutting-edge AI/ML startups. That breadth translates into solutions that are clinically sound, technically rigorous, and operationally practical.
Based in St. Louis, Missouri, Gateway Safety Solutions serves clients across the pharmaceutical, biotech, and life sciences sectors — delivering contract and FTE-adjacent consulting engagements remotely and on-site.
Dr. Paul A. Reed is the President, Founder, and Managing Consultant of Gateway Safety Solutions, LLC — a St. Louis-based pharmacovigilance consulting firm he established in 2014. With over two decades of experience at the intersection of drug safety science, enterprise technology, and regulatory compliance, Paul brings a perspective that is genuinely rare in the industry: equal fluency in clinical pharmacology and IT systems.
A 1994 Doctor of Pharmacy graduate of St. Louis College of Pharmacy and a BS MIS graduate of Maryville University, Paul began his career in pharmaceutical drug safety at Forest Laboratories, where he spent over a decade developing deep operational expertise in ICSR processing, safety system management, and regulatory reporting — expertise that carried through the company's acquisition by Allergan. Following that tenure, he expanded into global consulting through engagements with Nextrove, Genpact, and Insife/Qinecsa, delivering pharmacovigilance system implementations and GxP validation programs for multinational pharmaceutical clients across the US and EU.
Most recently, through Gateway Safety Solutions, Paul served as Head of Client Delivery for a pharmacovigilance AI startup, leading enterprise client implementations of an NLP-powered adverse event intake platform — overseeing quality assurance, validation, and go-live delivery. He is a registered pharmacist in both Missouri and Illinois, and brings hands-on expertise across all major safety database platforms, GxP/CSV validation frameworks, ICH E2B(R2/R3) regulatory requirements, and emerging AI/ML integration in drug safety workflows.
Open to contract, FTE, and advisory engagements. Remote-friendly.
Available for contract engagements, FTE opportunities, and advisory discussions. Response within one business day.
Thank you for reaching out to Gateway Safety Solutions. Dr. Reed will respond within one business day.